Replies to post #293274 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

Trials were not what was being discussed. The subject was New Drug Applications (NDA).

I agree with your point. The previous P1 & P2 trials will advance things to P3 quicker. The exception being the pediatric trial for Rett. That is the first pediatric trial so the FDA is properly very cautious about2-73 and children. Whether the Rett pediatric trial will influence the Fragile X pediatric trial I do not know.

[ExtremelyBullishZig]

Not exactly.

Phase 1 is for safety regardless of the indication. Phase 2 is specific to the indication.

[nidan7500]

DFRAI

If they have phase 1 and 2 for a273, they should be able advance other orphan diseases much faster to phase 3

Agree that seems plausible.